Results 81 to 90 of about 51,662 (290)
H. pylori infection is a major cause of stomach cancer, but its effect on immune cells in tumors is unclear. Using single‐cell sequencing, we mapped the stomach tumor environment and discovered a specific exhausted T‐cell subtype, marked by the FYB1 gene, that is abundant in H. pylori‐positive tumors and linked to patient prognosis. Our findings reveal
Yanhui Yang +22 more
wiley +1 more source
Polymorphic Mucocutaneous Eruption and Septic Shock in a 75‐Year‐Old Man
JEADV Clinical Practice, EarlyView.
Sweta Subhadarshani +2 more
wiley +1 more source
Immunoprofiling Reveals GATA3 as a Prognostic Marker in Transformed Mycosis Fungoides
ABSTRACT Transformed mycosis fungoides (TMF) is a rare, aggressive variant of cutaneous T‐cell lymphoma characterized by the presence of large neoplastic cells and poor clinical outcomes. A retrospective cohort of 22 TMF patients was analyzed using immunohistochemistry on formalin‐fixed, paraffin‐embedded (FFPE) tissue for GATA3 (n = 20), T‐bet (n = 22)
Bruno de Castro e Souza +5 more
wiley +1 more source
Blue‐Gray Papules on the Chest and Face
JEADV Clinical Practice, EarlyView.
Sanjana Likki +5 more
wiley +1 more source
Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones
ABSTRACT Mycosis fungoides (MF) is a unique type of lymphoma with an excellent prognosis presenting with a wide variety of clinical and histological findings. Recent sophisticated research techniques have revealed that very slow changes in the clinical and histological pictures of one patient over time are due to intratumoral heterogeneity.
Ryoma Honda +2 more
wiley +1 more source
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
Primary cutaneous lymphomas comprise a group of lymphatic malignancies that occur primarily in the skin. They represent the second most common form of extranodal non-Hodgkin’s lymphoma and are characterized by heterogeneous clinical, histological ...
Kazuyasu Fujii
doaj +1 more source
Personalized Cancer Vaccines in the Clinical Trial Pipeline
This study analyzes the current landscape of personalized cancer vaccine clinical trials, highlighting trends in vaccine platforms, trial phases, and geographic distribution. Peptide and dendritic cell vaccines dominate early‐stage research, with promising immune responses observed in melanoma, glioblastoma, and urothelial cancer trials.
Liudmila Iamukova, Elena Alferova
wiley +1 more source
T-Cell Lymphoblastic Lymphoma with Cutaneous Involvement in a Child: A Rare Case Report
Jiaoquan Chen,* Xin Tian,* Nanji Yu, Liqian Peng, Huilan Zhu Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, People’s Republic of China*These authors contributed equally to this workCorrespondence: Huilan Zhu,
Chen J, Tian X, Yu N, Peng L, Zhu H
doaj

